Dr. Barry Dworkin

In vitro study shows mouthwash component has antiviral effect against SARS-CoV2. However that is a long way away from any clinical use if ever.

Medical Mythbusting Commentary for October 7, 2022

Source:
Mouthwashes may suppress SARS-CoV-2

Reference:
Antiviral effect of cetylpyridinium chloride in mouthwash on SARS-CoV-2

Related posts:

  1. Interesting laboratory study on how blood type A antigens on respiratory cells’ surface may provide another way for SARS-CoV-2 to enter the body increasing infection risk. However, no clinical outcome data as this looked only at in vitro effects.
  2. Headline: “Scientists find potential cure for COVID-related loss of smell.” Not so fast. It concludes that greater improvement with treatment was noted compared to placebo but “there was no subjective olfactory improvement over placebo.”
  3. Heparin seems to reduce progression of COVID-19 in hospitalized people with moderate symptoms but not for the critically ill. Study author states that more research required to find the therapeutic “sweet spot”.
  4. Small in vitro study suggests two new COVID subvariants may dodge natural immunity response. However whether this translates into worsening clinical outcomes remains unanswered.